Toray Industries, Inc. (3402.T)
Tokyo, JP
Headquartered in Tokyo, Japan, Toray Industries, Inc. is a global conglomerate, established in 1926, that develops, manufactures, and distributes a comprehensive range of advanced materials and innovative products. Through its worldwide network of subsidiaries, the company's extensive operations encompass several key divisions. It produces a wide variety of fibers and textiles, including filament and staple yarns, spun yarns, and woven and knitted fabrics made from materials like nylon, polyester, and acrylics, alongside non-woven textiles and apparel. Its performance chemicals segment delivers specialized resins (such as ABS, PBT, and PPS), molded plastic goods, polyolefin foams, diverse films, raw materials for synthetics, fine chemicals, and electronic and graphic materials. Toray is also a prominent supplier of carbon fibers and their composite materials. Beyond material science, the firm provides environmental and engineering solutions, including water treatment systems, industrial machinery, IT-related equipment, and construction materials. Additionally, it operates in the life sciences sector, offering pharmaceuticals and medical devices, and provides analytical and research services. Originally founded as Toyo Rayon Co., Ltd., the company rebranded to Toray Industries, Inc. in 1970, serving customers across Japan, China, North America, Europe, and numerous other international markets.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.60% | +1.63% | +0.43% | -6.13% | +11.31% | +10.30% | +23.43% | +52.45% | +66.40% | +22.80% | +192.05% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 3 | 0 |
| Buy | 4 | 0 |
| Hold | 3 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
-
Revenue growth Manufacturing - Textiles: +1.7%+0.9% Q1'26: +4.1% (vs Q1'25)
-
EPS growth Manufacturing - Textiles: +17.5%+8.3% Q1'26: +1,407.4% (vs Q1'25)
-
FCF margin FCF growth · Manufacturing - Textiles: +74.6%+4.8% Q1'26: +15.6% (vs Q1'25)
-
EBIT margin Manufacturing - Textiles: +5.8%+5.4% Q1'26: +5.5% (vs Q1'25)
-
ROIC Manufacturing - Textiles: +4.9%+4.5% Q1'26: +5.7% (vs Q1'25)
-
Share dilution Manufacturing - Textiles: +0.0%-5.7% ★ Q1'26: -4.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Manufacturing - Textiles: 1.32×3.35× Q1'26: 3.25× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 11 Rev. Ana. 11 EPS Ana. |
Mar 2027 11 Rev. Ana. 11 EPS Ana. |
Mar 2028 10 Rev. Ana. 10 EPS Ana. |
Mar 2029 2 Rev. Ana. 2 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.01T
est: 2.05T (-1.7%)
|
2.10T
est: 2.15T (-2.0%)
|
2.03T
est: 2.04T (-0.6%)
|
2.20T
est: 2.19T (+0.6%)
|
2.39T
est: 2.38T (+0.2%)
|
2.09T
est: 2.21T (-5.5%)
|
1.88T
est: 1.88T (+0.3%)
|
2.23T
est: 2.22T (+0.5%)
|
2.49T
est: 2.52T (-1.2%)
|
2.46T
est: 2.52T (-2.4%)
|
2.56T
est: 2.59T (-0.9%)
|
2.59T
2.50T – 2.66T
+0.2% YoY
|
2.72T
2.60T – 2.81T
+4.9% YoY
|
2.82T
2.68T – 2.93T
+3.8% YoY
|
2.96T
2.82T – 3.06T
+4.9% YoY
|
3.09T
2.94T – 3.19T
+4.3% YoY
|
| EBITDA |
212.55B
est: 195.60B (+8.7%)
|
254.69B
est: 205.38B (+24.0%)
|
244.45B
est: 194.87B (+25.4%)
|
261.14B
est: 209.61B (+24.6%)
|
254.78B
est: 227.87B (+11.8%)
|
243.36B
est: 211.64B (+15.0%)
|
206.34B
est: 179.45B (+15.0%)
|
250.58B
est: 212.01B (+18.2%)
|
216.30B
est: 240.89B (-10.2%)
|
226.37B
est: 255.27B (-11.3%)
|
268.88B
est: 261.55B (+2.8%)
|
262.04B
253.05B – 269.44B
+0.2% YoY
|
274.96B
263.06B – 283.80B
+4.9% YoY
|
285.50B
271.26B – 296.02B
+3.8% YoY
|
299.35B
285.39B – 309.69B
+4.9% YoY
|
312.29B
297.73B – 323.08B
+4.3% YoY
|
| EBIT |
123.48B
est: 85.50B (+44.4%)
|
154.48B
est: 89.78B (+72.1%)
|
146.89B
est: 85.18B (+72.4%)
|
156.46B
est: 91.62B (+70.8%)
|
141.47B
est: 99.61B (+42.0%)
|
128.64B
est: 92.51B (+39.0%)
|
90.52B
est: 78.44B (+15.4%)
|
130.21B
est: 92.68B (+40.5%)
|
89.93B
est: 105.30B (-14.6%)
|
97.18B
est: 119.44B (-18.6%)
|
139.79B
est: 122.37B (+14.2%)
|
122.60B
118.40B – 126.07B
+0.2% YoY
|
128.65B
123.08B – 132.78B
+4.9% YoY
|
133.58B
126.92B – 138.50B
+3.8% YoY
|
140.06B
133.53B – 144.90B
+4.9% YoY
|
146.12B
139.30B – 151.17B
+4.3% YoY
|
| Net Income |
71.02B
est: 77.59B (-8.5%)
|
90.13B
est: 90.76B (-0.7%)
|
99.42B
est: 95.31B (+4.3%)
|
95.92B
est: 99.86B (-4.0%)
|
79.37B
est: 90.59B (-12.4%)
|
84.23B
est: 62.36B (+35.1%)
|
45.79B
est: 40.93B (+11.9%)
|
84.24B
est: 95.76B (-12.0%)
|
72.82B
est: 75.26B (-3.2%)
|
21.90B
est: 34.81B (-37.1%)
|
77.91B
est: 91.23B (-14.6%)
|
79.92B
74.31B – 91.36B
-12.4% YoY
|
103.86B
102.74B – 143.82B
+29.9% YoY
|
120.42B
115.10B – 164.77B
+15.9% YoY
|
131.97B
127.78B – 149.00B
+9.6% YoY
|
141.82B
133.22B – 148.19B
+7.5% YoY
|
| SGA |
211.60B
est: 288.83B (-26.7%)
|
223.14B
est: 303.28B (-26.4%)
|
218.60B
est: 287.76B (-24.0%)
|
228.53B
est: 309.52B (-26.2%)
|
240.18B
est: 336.49B (-28.6%)
|
233.85B
est: 312.52B (-25.2%)
|
286.98B
est: 264.99B (+8.3%)
|
305.76B
est: 313.07B (-2.3%)
|
330.91B
est: 355.72B (-7.0%)
|
346.34B
est: 356.35B (-2.8%)
|
366.11B
est: 365.12B (+0.3%)
|
365.80B
353.25B – 376.13B
+0.2% YoY
|
383.84B
367.23B – 396.18B
+4.9% YoY
|
398.56B
378.68B – 413.24B
+3.8% YoY
|
417.89B
398.40B – 432.33B
+4.9% YoY
|
435.96B
415.62B – 451.02B
+4.3% YoY
|
| EPS |
44.33
est: 48.64 (-8.9%)
|
56.38
est: 56.89 (-0.9%)
|
62.17
est: 59.74 (+4.1%)
|
59.97
est: 62.60 (-4.2%)
|
49.61
est: 56.79 (-12.6%)
|
52.63
est: 39.09 (+34.6%)
|
28.61
est: 25.66 (+11.5%)
|
52.63
est: 60.03 (-12.3%)
|
45.49
est: 47.45 (-4.1%)
|
13.67
est: 21.73 (-37.1%)
|
48.93
est: 57.64 (-15.1%)
|
53.16
46.58 – 57.27
-7.8% YoY
|
71.79
64.40 – 90.16
+35.1% YoY
|
82.68
72.15 – 103.29
+15.2% YoY
|
86.75
80.10 – 93.40
+4.9% YoY
|
88.90
83.51 – 92.89
+2.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B | 3/5 | 3/5 | 2/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-11 | B | 3/5 | 3/5 | 2/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-08 | B | 3/5 | 3/5 | 2/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-07 | B | 3/5 | 3/5 | 2/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-01 | B | 3/5 | 3/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-30 | B | 3/5 | 3/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-28 | B | 3/5 | 3/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-27 | B | 3/5 | 3/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-24 | B | 3/5 | 3/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-23 | B | 3/5 | 3/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-22 | B | 3/5 | 3/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-21 | B | 3/5 | 3/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-20 | B | 3/5 | 3/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-17 | B | 3/5 | 3/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-16 | B | 3/5 | 3/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Xtrackers MSCI AC Asia ex Japan ESG Swap UCITS ETF 1C XAXD.L | 1.48% | 5.02M | 0.65% |
| 2 | Desjardins RI Developed ex-USA exCanada Multifactor - Net-Zero Emissions DRFD.TO | 0.85% | 1.94M | 0.45% |
| 3 | iShares MSCI Japan SRI UCITS ETF SUJD.AS | 0.82% | 372.2K | 0.20% |
| 4 | iShares MSCI Japan SRI UCITS ETF SUJP.L | 0.82% | 4.20M | 0.20% |
| 5 | iShares MSCI Japan SRI UCITS ETF JPSG.L | 0.82% | 250.7K | 0.25% |
| 6 | iShares MSCI World Materials Sector Advanced UCITS ETF WMTS.AS | 0.82% | 451.0K | 0.18% |
| 7 | WisdomTree Japan Opportunities Fund OPPJ | 0.80% | 2.25M | 0.58% |
| 8 | UBS MSCI Japan Socially Responsible UCITS ETF JPY dis JPSR.L | 0.67% | 4.00M | 0.19% |
| 9 | UBS MSCI Japan Socially Responsible UCITS ETF hEUR acc U1FB.DE | 0.67% | 3.99M | 0.22% |
| 10 | UBS (Lux) Fund Solutions – MSCI Pacific Socially Responsible UCITS ETF UIMT.DE | 0.51% | 5.07M | 0.28% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Mitsuo Ohya | President, Chief Executive Officer & Representative Director | 132M | male |
| Hiroshi Otani | Senior Vice President, GM of Water Treatment & Environment Division | — | male |
| Katsuyuki Yanai | Senior Vice President of Human Resources Division | — | — |
| Kazuhiko Shuto | Executive Advisor & Director | — | male |
| Kazuyuki Adachi | Permanent Advisor, Production Headquarters & Director | — | male |
| Kenichiro Miki | Executive Vice President of Marketing & Sales | — | male |
| Masahiko Okamoto | Managing Executive Officer, GM of General Aff, Legal Aff & Risk Mgmt dept, GM of Tokyo off and Director | — | male |
| Satoru Hagiwara | Permanent Advisor, Technical Center & Director | — | male |
| Shigeki Terada | Senior Executive Officer, Head of Corporate Planning Office & Director | — | — |
| Tetsuya Tsunekawa | Executive VP & Representative Director | — | male |
| Hirofumi Kobayashi | Senior Vice President of Pharmaceuticals & Medical Products Division | — | male |
| Yuichiro Kato | Senior Executive Officer, Head of Finance & Accounting Division, Controller and Director | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 3402.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
